Design and Discovery of Novel, Potent Pyrazinone-Based Thrombin Inhibitors with a Solubilizing Amino P1-P2-Linker

Author(s): S. Bulat , S. Bosio , M. A. Papadopoulos , S. Cerezo-Galvez , E. Grabowski , C. Rosenbaum , V. G. Matassa , I. Ott , G. Metz , J. Schamberger , R. Sekul , A. Feurer .

Journal Name: Letters in Drug Design & Discovery

Volume 3 , Issue 5 , 2006

Become EABM
Become Reviewer


The evolution of a novel class of pyrazinone direct thrombin inhibitors (DTIs) is described. In an effort to improve the solubility and thereby the drug-like properties of pyrazinones that possess non-basic P1 residues, a novel amino P1-P2 linker has been designed from X-ray thrombin-inhibitor complexes. Biochemical evaluation demonstrated that nanomolar binding affinity was attained, and X-ray co-crystal structures reveal an unprecedented binding mode that involves an interaction of the new amino linker with Glu192 of the active site of thrombin. A family of soluble pyrazinones has thereby emerged.

Keywords: Thrombin, pyrazinone, X-ray, binding mode, selectivity

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2006
Page: [289 - 292]
Pages: 4
DOI: 10.2174/157018006777574203
Price: $58

Article Metrics

PDF: 4